Literature DB >> 19896686

IFN-alpha expression and antiviral effects are subtype and cell type specific in the cardiac response to viral infection.

Lianna Li1, Barbara Sherry.   

Abstract

The interferon-beta (IFN-beta) response is critical for protection against viral myocarditis in several mouse models, and IFN-alpha or -beta treatment is beneficial against human viral myocarditis. The IFN-beta response in cardiac myocytes and cardiac fibroblasts forms an integrated network for organ protection; however, the different IFN-alpha subtypes have not been studied in cardiac cells. We developed a quantitative RT-PCR assay that distinguishes between 13 highly conserved IFN-alpha subtypes and found that reovirus T3D induces five IFN-alpha subtypes in primary cardiac myocyte and fibroblast cultures: IFN-alpha1, -alpha2, -alpha4, -alpha5, and -alpha8/6. Murine IFN-alpha1, -alpha2, -alpha4, or -alpha5 treatment induced IRF7 and ISG56 and inhibited reovirus T3D replication in both cell types. This first investigation of IFN-alpha subtypes in cardiac cells for any virus demonstrates that IFN-alpha is induced in cardiac cells, that it is both subtype and cell type specific, and that it is likely important in the antiviral cardiac response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896686      PMCID: PMC2787694          DOI: 10.1016/j.virol.2009.10.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  67 in total

Review 1.  Toll-like receptor and RIG-I-like receptor signaling.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

2.  Differential constitutive expression of interferon genes in early mouse embryos.

Authors:  E Riego; A Pérez; R Martínez; F O Castro; R Lleonart; J de la Fuente
Journal:  Mol Reprod Dev       Date:  1995-06       Impact factor: 2.609

Review 3.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

4.  Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.

Authors:  N C Zoumbos; P Gascon; J Y Djeu; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Type I interferons produced by dendritic cells promote their phenotypic and functional activation.

Authors:  Maria Montoya; Giovanna Schiavoni; Fabrizio Mattei; Ion Gresser; Filippo Belardelli; Persephone Borrow; David F Tough
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

6.  Poly (I:C) induced immune response in lymphoid tissues involves three sequential waves of type I IFN expression.

Authors:  Thomas Démoulins; Marie-Laurence Baron; Nadia Kettaf; Ali Abdallah; Ehssan Sharif-Askari; Rafick-Pierre Sékaly
Journal:  Virology       Date:  2009-02-20       Impact factor: 3.616

7.  Characterization of the murine alpha interferon gene family.

Authors:  Vincent van Pesch; Hanane Lanaya; Jean-Christophe Renauld; Thomas Michiels
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  Cytopathogenic effect in cardiac myocytes but not in cardiac fibroblasts is correlated with reovirus-induced acute myocarditis.

Authors:  C J Baty; B Sherry
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7.

Authors:  M Sato; N Hata; M Asagiri; T Nakaya; T Taniguchi; N Tanaka
Journal:  FEBS Lett       Date:  1998-12-11       Impact factor: 4.124

10.  Subclassification of dilated cardiomyopathy and interferon treatment.

Authors:  M Stille-Siegener; A Heim; H R Figulla
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

View more
  19 in total

1.  Induction of IFN-α subtypes and their antiviral activity in mumps virus infection.

Authors:  Maja Markušić; Maja Šantak; Tanja Košutić-Gulija; Mladen Jergović; Renata Jug; Dubravko Forčić
Journal:  Viral Immunol       Date:  2014-12       Impact factor: 2.257

2.  NF-κB activation is cell type-specific in the heart.

Authors:  Efraín E Rivera-Serrano; Barbara Sherry
Journal:  Virology       Date:  2016-12-30       Impact factor: 3.616

3.  Spontaneous activation of a MAVS-dependent antiviral signaling pathway determines high basal interferon-β expression in cardiac myocytes.

Authors:  Efraín E Rivera-Serrano; Nicole DeAngelis; Barbara Sherry
Journal:  J Mol Cell Cardiol       Date:  2017-08-16       Impact factor: 5.000

4.  Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.

Authors:  Luna A Zaritsky; Jacquelyn R Bedsaul; Kathryn C Zoon
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

5.  Reovirus Efficiently Reassorts Genome Segments during Coinfection and Superinfection.

Authors:  Timothy W Thoner; Madeline M Meloy; Jacob M Long; Julia R Diller; James C Slaughter; Kristen M Ogden
Journal:  J Virol       Date:  2022-09-12       Impact factor: 6.549

6.  Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.

Authors:  Lauren M Smith; Lisa E Hensley; Thomas W Geisbert; Joshua Johnson; Andrea Stossel; Anna Honko; Judy Y Yen; Joan Geisbert; Jason Paragas; Elizabeth Fritz; Gene Olinger; Howard A Young; Kathleen H Rubins; Christopher L Karp
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

7.  In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.

Authors:  Nadine Althof; Stephanie Harkins; Christopher C Kemball; Claudia T Flynn; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

Review 8.  IFN-α subtypes: distinct biological activities in anti-viral therapy.

Authors:  K Gibbert; J F Schlaak; D Yang; U Dittmer
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

9.  Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent.

Authors:  Philippa Hillyer; Viraj P Mane; Lynnsie M Schramm; Montserrat Puig; Daniela Verthelyi; Aaron Chen; Zeng Zhao; Maria B Navarro; Kevin D Kirschman; Srikant Bykadi; Ronald G Jubin; Ronald L Rabin
Journal:  Immunol Cell Biol       Date:  2012-01-17       Impact factor: 5.126

10.  c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3.

Authors:  Iwona A Buskiewicz; Andreas Koenig; Brian Roberts; Jennifer Russell; Cuixia Shi; Sun-Hwa Lee; Jae U Jung; Sally A Huber; Ralph C Budd
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.